Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Don Miller who wrote (3108)	5/31/1999 8:01:00 PM
From: jeffbas	Read Replies (1) \| Respond to of 10280

On CBS TV item, I do not recall mention of a company. I think they showed a bottle for a second, which was too short to read. Perhaps their website would have some info. The point of my post, which I must not have been clear enough about, was NOT to challenge the comments made by the experts here but to point out that perception on Wall Street, marketing, financial incentives, and news coverage are important factors in the success of a drug and stock, over and above technical product merits, when differences are not major and the conditions are not life threatening. For example, if anti-IGE is only slightly better but substantially increases doctors' income through monthly office visits for a shot, as a layman I am not sure it would not have good success.